Adjuvant therapy for resected gastric carcinoma

Yuichi Kasakura, Alexandria Phan, Jaffer A Ajani

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Despite its continued decline over the past 40 years, gastric carcinoma is a common gastrointestinal cancer and a major health problem around the world. In Asian countries, such as Korea, Japan, Taiwan, and China, it remains one of the leading causes of cancer-related death. Similarly, it is a common malignancy in many South American countries, Eastern European countries, and many countries of the former Soviet Union. In North America, the incidence of gastric carcinoma is low; however, the incidence of proximal gastric carcinoma has risen over the past 15 years. In 2001, approximately 21,700 new cases and 12,800 deaths were estimated in the United States as a result of gastric carcinoma. In the United States, gastric cancer ranks 14th among all cancers in incidence rate and 10th in overall mortality rate. An early detection program has been established in Japan, where nearly 6,000,000 adults are screened annually. This type of mass screening for gastric cancer is not practiced elsewhere, however. Because the risk of relapse remains high for patients after a curative resection, there is a great need for effective adjuvant therapy for patients with gastric carcinoma.

Original languageEnglish (US)
Pages (from-to)431-444
Number of pages14
JournalSurgical Oncology Clinics of North America
Volume11
Issue number2
DOIs
StatePublished - Jan 1 2002

Fingerprint

Stomach
Carcinoma
Stomach Neoplasms
Incidence
Japan
Therapeutics
Neoplasms
Mass Screening
Gastrointestinal Neoplasms
USSR
Korea
North America
Taiwan
China
Recurrence
Mortality
Health

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Adjuvant therapy for resected gastric carcinoma. / Kasakura, Yuichi; Phan, Alexandria; Ajani, Jaffer A.

In: Surgical Oncology Clinics of North America, Vol. 11, No. 2, 01.01.2002, p. 431-444.

Research output: Contribution to journalReview article

Kasakura, Yuichi ; Phan, Alexandria ; Ajani, Jaffer A. / Adjuvant therapy for resected gastric carcinoma. In: Surgical Oncology Clinics of North America. 2002 ; Vol. 11, No. 2. pp. 431-444.
@article{7f0098dd9b694fb0a12b8d45823e656a,
title = "Adjuvant therapy for resected gastric carcinoma",
abstract = "Despite its continued decline over the past 40 years, gastric carcinoma is a common gastrointestinal cancer and a major health problem around the world. In Asian countries, such as Korea, Japan, Taiwan, and China, it remains one of the leading causes of cancer-related death. Similarly, it is a common malignancy in many South American countries, Eastern European countries, and many countries of the former Soviet Union. In North America, the incidence of gastric carcinoma is low; however, the incidence of proximal gastric carcinoma has risen over the past 15 years. In 2001, approximately 21,700 new cases and 12,800 deaths were estimated in the United States as a result of gastric carcinoma. In the United States, gastric cancer ranks 14th among all cancers in incidence rate and 10th in overall mortality rate. An early detection program has been established in Japan, where nearly 6,000,000 adults are screened annually. This type of mass screening for gastric cancer is not practiced elsewhere, however. Because the risk of relapse remains high for patients after a curative resection, there is a great need for effective adjuvant therapy for patients with gastric carcinoma.",
author = "Yuichi Kasakura and Alexandria Phan and Ajani, {Jaffer A}",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S1055-3207(02)00009-1",
language = "English (US)",
volume = "11",
pages = "431--444",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Adjuvant therapy for resected gastric carcinoma

AU - Kasakura, Yuichi

AU - Phan, Alexandria

AU - Ajani, Jaffer A

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Despite its continued decline over the past 40 years, gastric carcinoma is a common gastrointestinal cancer and a major health problem around the world. In Asian countries, such as Korea, Japan, Taiwan, and China, it remains one of the leading causes of cancer-related death. Similarly, it is a common malignancy in many South American countries, Eastern European countries, and many countries of the former Soviet Union. In North America, the incidence of gastric carcinoma is low; however, the incidence of proximal gastric carcinoma has risen over the past 15 years. In 2001, approximately 21,700 new cases and 12,800 deaths were estimated in the United States as a result of gastric carcinoma. In the United States, gastric cancer ranks 14th among all cancers in incidence rate and 10th in overall mortality rate. An early detection program has been established in Japan, where nearly 6,000,000 adults are screened annually. This type of mass screening for gastric cancer is not practiced elsewhere, however. Because the risk of relapse remains high for patients after a curative resection, there is a great need for effective adjuvant therapy for patients with gastric carcinoma.

AB - Despite its continued decline over the past 40 years, gastric carcinoma is a common gastrointestinal cancer and a major health problem around the world. In Asian countries, such as Korea, Japan, Taiwan, and China, it remains one of the leading causes of cancer-related death. Similarly, it is a common malignancy in many South American countries, Eastern European countries, and many countries of the former Soviet Union. In North America, the incidence of gastric carcinoma is low; however, the incidence of proximal gastric carcinoma has risen over the past 15 years. In 2001, approximately 21,700 new cases and 12,800 deaths were estimated in the United States as a result of gastric carcinoma. In the United States, gastric cancer ranks 14th among all cancers in incidence rate and 10th in overall mortality rate. An early detection program has been established in Japan, where nearly 6,000,000 adults are screened annually. This type of mass screening for gastric cancer is not practiced elsewhere, however. Because the risk of relapse remains high for patients after a curative resection, there is a great need for effective adjuvant therapy for patients with gastric carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0036545126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036545126&partnerID=8YFLogxK

U2 - 10.1016/S1055-3207(02)00009-1

DO - 10.1016/S1055-3207(02)00009-1

M3 - Review article

C2 - 12424861

AN - SCOPUS:0036545126

VL - 11

SP - 431

EP - 444

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 2

ER -